Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Progress in the treatment of chronic portasystemic encephalopathy.

× No keyword cloud information.

72 in total

1. Blood ammonia levels in hepatic cirrhosis: their control by the oral administration of neomycin.

Authors: C J FISHER; W W FALOON
Journal: N Engl J Med Date: 1957-05-30 Impact factor: 91.245

2. Blood ammonia levels following the ingestion of casein and whole blood.

Authors: A N BESSMAN; G S MIRICK
Journal: J Clin Invest Date: 1958-07 Impact factor: 14.808

3. Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

Authors: L Zieve; R L Olsen
Journal: Gut Date: 1977-09 Impact factor: 23.059

4. A controlled clinical trial of lactulose in hepatic encephalopathy.

Authors: F Simmons; H Goldstein; J D Boyle
Journal: Gastroenterology Date: 1970-12 Impact factor: 22.682

5. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.

Authors: J Bircher; U P Haemmerli; G Scollo-Lavizzari; K Hoffmann
Journal: Am J Med Date: 1971-08 Impact factor: 4.965

6. Gonococcal arthritis in children.

Authors: C W Fink
Journal: JAMA Date: 1965-10-18 Impact factor: 56.272

7. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors: H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal: Dig Dis Sci Date: 1981-07 Impact factor: 3.199

8. The role of plasma amino acids in hepatic encephalopathy.

Authors: J E Fischer; J M Funovics; A Aguirre; J H James; J M Keane; R I Wesdorp; N Yoshimura; T Westman
Journal: Surgery Date: 1975-09 Impact factor: 3.982

9. Ammonia production by intestinal bacteria.

Authors: A Vince; A M Dawson; N Park; F O'Grady
Journal: Gut Date: 1973-03 Impact factor: 23.059

10. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.

Authors: H Michel; M Solere; P Granier; G Cauvet; J P Bali; F Pons; H Bellet-Hermann
Journal: Gastroenterology Date: 1980-08 Impact factor: 22.682

3 in total

1. Vancomycin in resistant hepatic encephalopathy.

Authors: A Forbes; I Murray-Lyon
Journal: Gut Date: 1990-12 Impact factor: 23.059

Review 2. Medical aspects of gallstones--1985: sixty years on.

Authors: R H Dowling; D Gleeson
Journal: Postgrad Med J Date: 1985-10 Impact factor: 2.401

Review 3. Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.

Authors: J C Gillis; R N Brogden
Journal: Drugs Date: 1995-03 Impact factor: 9.546

3 in total